Government Forms Probe Committee Over Alleged Irregularities in Drug Pricing
Summary
The Nepalese government has formed a three-member committee to investigate alleged irregularities in the drug pricing process following official complaints.
Key Points
- The government has established an investigation committee over complaints of irregularities in drug pricing.
- The committee is led by Additional Health Secretary Dr. Shreekrishna Shrestha and includes legal and subject experts.
- The probe was initiated after the Office of the Prime Minister reported unlawful drug price increases by the Department of Drug Administration director general.
- The committee is tasked to investigate the pricing process, adherence to laws, and submit a report within seven days.
